Table 1.
Demographic and clinical OA characteristics of all subjects.
| Placebo | TCI633 | |
|---|---|---|
| Subject number (persons) | 30 | 37 |
| Age (years) | 60.8 (12.2) | 65.1 (9.3) |
| Female | 22 (73.3%) | 31 (83.8%) |
| Male | 8 (26.4%) | 6 (16.2%) |
| Body weight (kg) |
64 (11.1) |
62.7 (11.0) |
| Kellgren and Lawrence grading | ||
| Grade 1: baseline/12 weeks | 20 (66.7%)/19 (63.4%) | 12 (32.4%)/12 (32.4%) |
| Grade 2: baseline/12 weeks | 4 (13.3%)/4 (13.3%) | 12 (32.4%)/15 (40.6%) |
| Grade 3: baseline/12 weeks | 6 (20.0%)/6 (20.0%) | 13 (35.2%)/10 (27.0%) |
| Grade 4: baseline/12 weeks | N/A/1 (3.3%) | N/A |
Value indicates mean value (S.D./population percentage). Kellgren and Lawrence (K/L) grading represents: K/L 1: doubtful, K/L 2: mild, K/L 3: moderate, K/L 4: severe.